| Serial Number | 97635380 |
| Word Mark | CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA. DIVERSITY, EQUITY, AND INCLUSION |
| Filing Date | Monday, October 17, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 16, 2024 |
| Goods and Services | Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy |
| Description of Mark | The mark consists of a double helix to the left of the terms CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA DIVERSITY, EQUITY, AND INCLUSION. |
| Pseudo Mark | CRISPR THERAPEUTICS DE AND I IT IS IN OUR DNA DIVERSITY EQUITY AND INCLUSION |
| Section 2(f) Limitation Statement | As to "CRISPR THERAPEUTICS" |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "DE&I" AND "DIVERSITY, EQUITY, AND INCLUSION" |
| Goods and Services | Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 1, 2022 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 1, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 SWITZERLAND 6300 CH |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 SWITZERLAND 6300 CH |
| Event Date | Event Description |
| Thursday, October 20, 2022 | NEW APPLICATION ENTERED |
| Thursday, October 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, October 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, October 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, November 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 2, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, March 31, 2023 | ASSIGNED TO EXAMINER |
| Friday, June 30, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, March 31, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, March 31, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, March 31, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 30, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, July 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 18, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 12, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 12, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 11, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 11, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 12, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 16, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, October 14, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, October 14, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |